Evaluating the expression of immunohistochemical panel of p53, CDX2, IMP3 and AMCAR in grading dysplasia of Barrett’s esophagus and predicting the progression to esophageal adenocarcinoma

Author:

Bassyoni Omneya Y1,Abdalla Rana M1,Eleleimy Hiam A2

Affiliation:

1. Department of Pathology, Faculty of Medicine, Benha University, Qalyubiyah, Egypt

2. Department of Internal Medicine, Hemato-Oncology Unit, Faculty of Medicine, Benha University, Qalyubiyah, Egypt

Abstract

Abstract Objective Barrett’s esophagus (BE) is an established precursor to esophageal adenocarcinoma, which has a poor prognosis unless detected at an early stage. The progression of BE to adenocarcinoma is slow and unpredictable. Currently, the best predictor of adenocarcinoma is histological detection of dysplasia. Accurate grading of dysplasia and especially discriminating low-grade dysplasia LGD from high-grade dysplasia HGD is important for management. Marked variability exists when diagnosing dysplasia in BE. This highlights the need for a diagnostic adjunct, especially in histologically challenging cases. This study aims at evaluating the role of immunohistochemical expression of (p53, IMP3, AMCAR and CDx2) in Barrett’s oesophagus spectrum, to increase the diagnostic accuracy of grading dysplasia and predicting progression risk. Methods This is a retrospective immunohistochemical study, performed on selected 52 cases of esophageal biopsies. Results The p53 was negative in nondysplastic Barrett’s esophagus (ND-BE) and LGD and strong positivity towards HGD/esophageal adenocarcinoma (EAC). CDX2 showed highest expression among ND-BE and decreased towards EAD. IMP3 and AMCAR were negative in all cases of ND-BE with gradual increase among HGD/esophageal adenocarcinoma cases. IMP3, AMCAR, and CDX2 were found to be more sensitive in detecting HGD (80%, 70% & 70%). Meanwhile, p53 is more specific (100%), IMP3 and AMCAR are more sensitive discriminating LGD from HGD (80%) than p53 and CDX2 (60%, 70%). Conclusion This combined panel of p53, CDX2, IMP3, and AMACR could be used in conjunction with histology as a promising tool to accurately predict progression form BE to HGD/adenocarcinoma with a great value for early detecting high grade dysplasia, discriminating it from LGD, improving risk stratification in BE, and optimizing patient care.

Publisher

Medknow

Subject

General Earth and Planetary Sciences,General Environmental Science

Reference42 articles.

1. The role of esophagectomy in the management of Barrett’s esophagus with high-grade dysplasia;Badgery;Ann N Y Acad Sci,2020

2. p53 gene mutation and protein accumulation during neoplastic progression in Barrett’s esophagus;Bian;Mod Pathol,2001

3. The Cdx2 homeobox gene has a tumour suppressor function in the distal colon in addition to a homeotic role during gut development;Bonhomme;Gut,2003

4. IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers and normal tissues;Burdelski;Oncol Rep,2018

5. Aberrant p53 expression is associated with neoplastic progression in Barrett oesophagus diagnosed as indefinite for dysplasia;Chen;Histopathology,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3